Skip to main content Accessibility help
×
Home

Toxic psychosis? Duration of untreated psychosis, symptomatology and cognitive deterioration in first episode psychosis

  • Richard Lawoyin (a1), Keith Gaynor (a2) (a3), Barbara Dooley (a3), Elizabeth Lawlor (a4), Mary Clarke (a5) and Eadbhard O'Callaghan (a6) (a7)...

Abstract

Objectives: To examine the relationship between cognitive deficits, the duration of untreated psychosis (DUP) and positive and negative symptoms in a first episode psychosis sample.

Method: We assessed a consecutive sample of first episode psychosis participants from a catchment area service with a comprehensive neuropsychology battery, a family and service-user based measure of DUP and measures of symptomatology.

Results: Using correlations and stepwise linear regressions, we found strong relationships between measures of DUP and positive symptomatology. We found that positive and negative symptoms were associated with different time periods within DUP. However, we did not find evidence of a relationship between DUP and cognitive factors.

Conclusions: There was no evidence of a relationship between DUP and cognitive deterioration. However, there does appear to be evidence of a relationship between positive symptoms and aspects of DUP. These results highlight the importance of the heterogeneity of DUP and the potential to reduce positive symptoms through early intervention.

Copyright

Corresponding author

Correspondence Email: keith.gaynor@gmail.com

References

Hide All
1.Norman, RMG, Malla, KA. Duration of untreated psychosis: a critical evaluation of the concept and its importance. Psychol Med 2001; 31: 381400.
2.Skeate, A, Jackson, C, Birchwood, M, Jones, C. Duration of untreated psychosis and pathways to care in first episode psychosis: investigation of help seeking behaviour in primary care. Br J Psychiatry (Suppl) 2002; 181(43): S73S77.
3.Browne, S, Clarke, M, Gervin, M, Waddington, JL, Larkin, C, O'Callaghan, E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000;176:173–6.
4.Harris, MGet al.The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005; 79: 8593.
5.Keshavan, MS, Berger, G, Zipursky, RB, Wood, SJ, Pantelis, C. Neurobiology of early psychosis. Br J Psychiatry (Suppl) 2005; 187: S8S18.
6.Wyatt, R. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophr Res 1991; 5: 201–2.
7.Harrop, CE, Trower, P. Why does schizophrenia develop at late adolescence? Chichester: Wiley, 2003.
8.Heinrichs, RW, Zakzanis, KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426–45.
9.Byrne, Met al.Neuropsychology, genetic liability and psychotic symptoms in those at high risk of schizophrenia. J Abnorm Psychol 2002; 112: 3848.
10.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington DC: American Psychiatric Association, 1994.
11.Beiser, M, Erickson, D, Fleming, JAE, Iacono, WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349–54.
12.Andreasen, NC. The scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa, 1983b.
13.Andreasen, NC. The scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa, 1983a.
14.Malla, AK, Norman, RM, Manchada, R. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002; 32: 1109–19.
15.Thorup, Aet al.Integrated treatment ameliorates negative symptoms in first episode psychosis – results from the Danish OPUS trial. Schizophr Res 2005; 79: 95105.
16.Taylor, D, Patton, C, Kerwin, R. The South London and Maudsley NHS Trust Prescribing Guidelines (7th ed). Martin Dunitz: London, 2003.
17.ORYGEN Early Psychosis Service. First Episode Psychosis Survey Guidelines. Personal Communication. Melbourne, 2005
18.Wechsler, D. Wechsler Adult Intelligence Scale (3rd ed). New York: Psychological Corporation, 1997a.
19.Wechsler, D. Wechsler Test of Adult Reading. New York: Psychological Corporation, 2001.
20.Conners, CK. CPT: Connors' Continuous Performance Test. Toronto: Multi-Health Systems, 1995.
21.Spreen, O, Strauss, E. A compendium of neuropsychological tests: administration, norms and commentary. London: Oxford University Press, 1991.
22.Lezack, MD. Neuropsychological Assessment. New York: Oxford University Press, 1995.
23.Wilson, BA, Alderman, N, Burgess, PW, Emslie, H, Evans, JJ. Behavioural Assessment of the Dysexecutive Syndrome. St Edmunds, UK: Thames Valley Test Company, 1996.
24.Wechsler, D. The measurement and appraisal of adult intelligence. Baltimore: Williams and Wilkins Company, 1958.
25.Amminger, GP, Edwards, J, McGorry, PD. Estimating cognitive deterioration in schizophrenia. Br J Psychiatry 2002; 181: 164.
26.Russsell, AJ, Munro, J, Jones, PB, Hayward, P, Hemsely, DR, Murray, RM. The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. Br J Clin Psychol 2000; 39: 297305
27.Bilder, RM, Mukherjee, S, Rieder, RO, Pandurangi, AK. Symptomatic and neuropsychological components of defect states. Schizophr Bull 1985; 11: 409–19
28.Norman, RMG, Townsend, L, Malla, AK. Duration of untreated psychosis and cognitive functioning in first episode patients. Br J Psychiatry 2001; 179: 340–5.
29.Friss, Set al.Effects of an early detection program on duration of untreated psychosis: part of the Scandinavian TIPS study. Br J Psychiatry (Suppl) 2005; 48: S29S32.
30.Woodward, ND, Purdon, SE, Meitzer, HY, Zald, DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharm 2005; 8: 457–72.
31.Goldberg, TE, Weinberger, DR, Berman, KF, Pliskin, NH, Podd, MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44: 1008–14.
32.Keefe, RS, Silva, SG, Perkins, DO, Lieberman, JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999; 25: 201–22.
33.Amminger, GP, Edwards, J, Brewer, WJ, Harrigan, S, McGorry, PD. Duration of untreated psychosis and cognitive deterioration in first episode schizophrenia. Schizophr Res 2002; 54: 223–30.
34.Barnes, TR, Hutton, SB, Chapman, MJ, Mutsatsa, S, Puri, BK, Joyce, EM. West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177: 207–11.
35.Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62(9): 975–83.

Keywords

Related content

Powered by UNSILO

Toxic psychosis? Duration of untreated psychosis, symptomatology and cognitive deterioration in first episode psychosis

  • Richard Lawoyin (a1), Keith Gaynor (a2) (a3), Barbara Dooley (a3), Elizabeth Lawlor (a4), Mary Clarke (a5) and Eadbhard O'Callaghan (a6) (a7)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.